Market Research Logo

Europe Stem Cell Market Forecast 2018-2026

Europe Stem Cell Market Forecast 2018-2026

KEY FINDINGS

Different cultures have varying attitudes toward the desirability of using stem cells. However, the European market has always been supportive of biotechnological research and is blessed with a number of institutes and universities that are engaged in the same. Driven by this fact, the Europe stem cell market is anticipated to register a CAGR of 9.45% by the end of the forecast period of 2018-2026.

MARKET INSIGHTS

Several European markets analyzed in this region include UK, Germany, France, Spain, Italy and rest of Europe. In the year 2017, UK and Germany were significant contributors to this region. In fact, the UK has played a critical role in the first fully approved bone marrow transplantation using stem cell therapy. On the other hand, the German market is majorly being driven by its advanced healthcare facility and growing elderly population

COMPETITIVE INSIGHTS

The Europe stem cell market is developing owing to the presence of eminent market companies like Becton Dickinson, Ge Healthcare, Fibrocell Science Inc, Celgene Corporation, Thermo Fisher Vericel Corporation (Formerly Aastrom Bioscience), Kangstem Biotech Ltd, Biotime Inc, Corestem Inc, Corning Inc., Brainstorm Cell Therapeutics, Stemedica Cell Technologies Inc and Cytori Therapeutics.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Regenerative Medicine Is The Emerging Branch Of Medical Science
3.2.2. Use Of Adult Stem Cells Has Been Significant
4. Market Determinants
4.1. Market Driver
4.1.1. Potential Of Stem Cells In Regenerative Medicine
4.1.2. Key To Anti-ageing And Prolonging Life
4.1.3. Increasing R&D Investments In Adult Stem Cell Research
4.1.4. Ease Of Administration
4.1.5. Reduced Risk Of Tissue Rejection In Transplants
4.2. Market Restraints
4.2.1. Safety Issues
4.2.2. Ethical Issues
4.3. Opportunities
4.3.1. Technological Innovations
4.3.2. Emerging Application As A Drug Discovery Tool
4.3.3. Other Promising Applications
4.4. Market Challenges
4.4.1. Stringent Government Regulations
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Adult Stem Cell Market
5.1.1.1. Hematopoietic Stem Cell Market
5.1.1.2. Mesenchymal Stem Cell Market
5.1.1.3. Neural Stem Cell Market
5.1.1.4. Dental Stem Cell Market
5.1.1.5. Umbilical Cord Stem Cell Market
5.1.2. Human Embryonic Stem Cell
5.1.3. Induced Pluripotent Stem Cell Market
5.1.4. Rat Neural Stem Cell Market
5.2. Market By Technology 2018-2026
5.2.1. Stem Cell Acquisition
5.2.1.1. Stem Cell Bone Marrow Market
5.2.1.2. Stem Cell Apheresis Market
5.2.1.3. Umbilical Cord Blood Market
5.2.2. Stem Cell Production
5.2.2.1. Therapeutic Cloning
5.2.2.2. Ivf Stem Cell
5.2.2.3. Stem Cell Culture
5.2.3. Stem Cell Cryopreservation
5.2.4. Stem Cells Expansion And Sub-culture
5.3. Market By Application 2018-2026
5.3.1. Regenerative Medicine
5.3.2. Drug Discovery And Development
6. Key Analytics
6.1. Porter’s Five Forces Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products Or Services
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Value Chain Analysis
6.3. Opportunity Matrix
6.4. Key Buying Criteria
6.4.1. High Price
6.4.2. Efficacy
6.4.3. Application And Effectiveness
6.4.4. Accuracy
6.5. Pest Analysis
6.6. History Of Stem Cell
6.7. Patent Analysis
6.7.1. Stem Cell Patent In Europe
6.8. Regulatory Frame Work
7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Spain
7.1.5. Italy
7.1.6. Rest Of Europe
8. Company Profile
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Becton Dickinson
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Biotime Inc
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Brainstorm Cell Therapeutics
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Celgene Corporation
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Cellular Dynamics International (Holding Company Fujifilm)
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Cellular Engineering Technologies Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Corestem Inc
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Corning Inc.
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Cytori Therapeutics
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Fibrocell Science Inc
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Ge Healthcare
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Kangstem Biotech Ltd
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Strategic Initiatives
8.14. Stemedica Cell Technologies Inc
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Strategic Initiatives
8.15. Stryker Corporation
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
8.16. Takara Holdings Inc.
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiatives
8.17. Thermo Fisher
8.17.1. Company Overview
8.17.2. Product Portfolio
8.17.3. Scot Analysis
8.17.4. Strategic Initiatives
8.18. Vericel Corporation (Formerly Aastrom Bioscience)
8.18.1. Company Overview
8.18.2. Product Portfolio
8.18.3. Scot Analysis
8.18.4. Strategic Initiatives
Table List
Table 1 Europe Stem Cell Market 2018-2026 ($ Million)
Table 2 Europe Stem Cells Market By Products 2018-2026 ($ Million)
Table 3 Europe Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Table 4 Europe Stem Cell Market In Adult Stem Cell By Types 2018-2026 ($ Million)
Table 5 Europe Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Table 6 Europe Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Table 7 Europe Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Table 8 Europe Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Table 9 Europe Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Table 10 Europe Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Table 11 Europe Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Table 12 Europe Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Table 13 Europe Stem Cell Market By Technology 2018-2026 ($ Million)
Table 14 Europe Stem Cell Market In Acquisition By Types 2018-2026 ($ Million)
Table 15 Europe Stem Cell Market In Acquisition 2018-2026 ($ Million)
Table 16 Europe Stem Cell Acquisition Market In Bone Marrow By Geography 2018-2026 ($ Million)
Table 17 Europe Stem Cell Acquisition Market In Cell Apheresis 2018-2026 ($ Million)
Table 18 Europe Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Table 19 Europe Stem Cell Market In Production By Types 2018-2026 ($ Million)
Table 20 Europe Stem Cell Market In Production 2018-2026 ($ Million)
Table 21 Europe Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Table 22 Europe Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Table 23 Europe Stem Cell Production Market In Stem Cell Culture 2018-2026 ($ Million)
Table 24 Europe Stem Cell Market In Stem Cell Cryopreservation 2018-2026 ($ Million)
Table 25 Europe Stem Cell Market In Stem Cell Expansion And Sub-culture 2018-2026 ($ Million)
Table 26 Europe Stem Cells Market By Application 2018-2026 ($ Million)
Table 27 Europe Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Table 28 Europe Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Table 29 Europe Stem Cell Market By Country 2018-2026 (In $ Million)
Figures List
Figure 1 Europe Stem Cell Market 2018-2026 ($ Million)
Figure 2 Europe Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Figure 3 Europe Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Figure 4 Europe Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Figure 5 Europe Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Figure 6 Europe Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Figure 7 Europe Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Figure 8 Europe Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Figure 9 Europe Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Figure 10 Europe Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Figure 11 Europe Stem Cell Market In Acquisition 2018-2026 ($ Million)
Figure 12 Europe Stem Cell Acquisition Market In Bone Marrow 2018-2026 ($ Million)
Figure 13 Europe Stem Cell Acquisition Market In Apheresis 2018-2026 ($ Million)
Figure 14 Europe Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Figure 15 Europe Stem Cell Market In Production 2018-2026 ($ Million)
Figure 16 Europe Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Figure 17 Europe Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Figure 18 Europe Stem Cell Production Market In Stem Cells Culture 2018-2026 ($ Million)
Figure 19 Europe Stem Cell Market In Stem Cells Cryopreservation 2018-2026 ($ Million)
Figure 20 Europe Stem Cell Market In Stem Cell Expansion And Sub-culture 2018-2026 ($ Million)
Figure 21 Europe Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Figure 22 Europe Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Figure 23 The United Kingdom Stem Cell Market 2018-2026 (In $ Million)
Figure 24 France Stem Cell Market, 2018-2026 (In $ Million)
Figure 25 Germany Stem Cell Market 2018-2026 (In $ Million)
Figure 26 Spain Stem Cell Market 2018-2026 (In $ Million)
Figure 27 Italy Stem Cell Market 2018-2026 (In $ Million)
Figure 28 Rest Of Europe Stem Cell Market 2018-2026 (In $ Million)
Figure 29 Stem Cell

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report